Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.32M | -1.92M | -1.43M | -1.60M | -1.96M |
| Total Depreciation and Amortization | 50.40K | 49.60K | 48.80K | 31.60K | 38.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00 | 2.90K | 5.90K | 36.80K | -1.10K |
| Change in Net Operating Assets | 774.30K | 277.60K | -79.80K | 169.50K | -134.70K |
| Cash from Operations | -1.50M | -1.59M | -1.45M | -1.36M | -2.05M |
| Capital Expenditure | -142.80K | -19.00K | -173.70K | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 3.70K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -142.80K | -15.30K | -173.70K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.10K | -1.10K | -1.00K | -1.00K | -1.00K |
| Issuance of Common Stock | 8.50M | 125.10K | 4.50M | 0.00 | 3.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -942.30K | -- | -787.80K | 0.00 | -464.70K |
| Cash from Financing | 7.56M | 124.10K | 3.71M | -1.00K | 3.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.91M | -1.48M | 2.08M | -1.36M | 1.33M |